These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 35325695)
1. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex. Hu MH; Lin JH; Huang Q Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695 [TBL] [Abstract][Full Text] [Related]
3. Human MYC G-quadruplex: From discovery to a cancer therapeutic target. Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579 [TBL] [Abstract][Full Text] [Related]
4. Distinguishing G-Quadruplexes Stabilizer and Chaperone for c- Zhang Y; Cheng Y; Luo Q; Wu T; Huo J; Yin M; Peng H; Xiao Y; Tong Q; You H J Am Chem Soc; 2024 Feb; 146(6):3689-3699. PubMed ID: 38296825 [TBL] [Abstract][Full Text] [Related]
5. Chemical and structural studies provide a mechanistic basis for recognition of the MYC G-quadruplex. Calabrese DR; Chen X; Leon EC; Gaikwad SM; Phyo Z; Hewitt WM; Alden S; Hilimire TA; He F; Michalowski AM; Simmons JK; Saunders LB; Zhang S; Connors D; Walters KJ; Mock BA; Schneekloth JS Nat Commun; 2018 Oct; 9(1):4229. PubMed ID: 30315240 [TBL] [Abstract][Full Text] [Related]
6. Development of a fluorescent ligand that specifically binds to the c-MYC G-quadruplex by migrating the benzene group on a carbazole-benzothiazolium scaffold. Wang R; Hu MH Bioorg Chem; 2024 Oct; 151():107690. PubMed ID: 39098087 [TBL] [Abstract][Full Text] [Related]
7. Identification of G-Quadruplex-Binding Inhibitors of Myc Expression through Affinity Selection-Mass Spectrometry. Flusberg DA; Rizvi NF; Kutilek V; Andrews C; Saradjian P; Chamberlin C; Curran P; Swalm B; Kattar S; Smith GF; Dandliker P; Nickbarg EB; O'Neil J SLAS Discov; 2019 Feb; 24(2):142-157. PubMed ID: 30204533 [TBL] [Abstract][Full Text] [Related]
8. Custom G4 Microarrays Reveal Selective G-Quadruplex Recognition of Small Molecule BMVC: A Large-Scale Assessment of Ligand Binding Selectivity. Wu G; Tillo D; Ray S; Chang TC; Schneekloth JS; Vinson C; Yang D Molecules; 2020 Jul; 25(15):. PubMed ID: 32751510 [TBL] [Abstract][Full Text] [Related]
9. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes. Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994 [TBL] [Abstract][Full Text] [Related]
11. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961 [TBL] [Abstract][Full Text] [Related]
12. Constructing triazole-modified quinazoline derivatives as selective c-MYC G-quadruplex ligands and potent anticancer agents through click chemistry. Cai JH; Yang DY; Zhang JJ; Tan JH; Huang ZS; Chen SB Bioorg Chem; 2024 Mar; 144():107173. PubMed ID: 38335759 [TBL] [Abstract][Full Text] [Related]
13. Targeting specific DNA G-quadruplexes with CRISPR-guided G-quadruplex-binding proteins and ligands. Qin G; Liu Z; Yang J; Liao X; Zhao C; Ren J; Qu X Nat Cell Biol; 2024 Jul; 26(7):1212-1224. PubMed ID: 38961283 [TBL] [Abstract][Full Text] [Related]
14. Non-fused imidazole-biphenyl analogs repress triple-negative breast cancer growth by mainly stabilizing the c-MYC G-quadruplex via a multi-site binding mode. Wang XD; Wang JX; Yu BY; Zhang SQ; Hu MH Bioorg Med Chem; 2023 Jun; 88-89():117336. PubMed ID: 37209638 [TBL] [Abstract][Full Text] [Related]
15. Structurally diverse G-quadruplexes as the noncanonical nucleic acid drug target for live cell imaging and antibacterial study. Zheng BX; Yu J; Long W; Chan KH; Leung AS; Wong WL Chem Commun (Camb); 2023 Feb; 59(11):1415-1433. PubMed ID: 36636928 [TBL] [Abstract][Full Text] [Related]
16. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription. Hu MH; Wu TY; Huang Q; Jin G Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090 [TBL] [Abstract][Full Text] [Related]
17. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex. Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069 [TBL] [Abstract][Full Text] [Related]
18. Specific Recognition of Promoter G-Quadruplex DNAs by Small Molecule Ligands and Light-up Probes. Dhamodharan V; Pradeepkumar PI ACS Chem Biol; 2019 Oct; 14(10):2102-2114. PubMed ID: 31532996 [TBL] [Abstract][Full Text] [Related]
19. Insight Derived from Molecular Dynamics Simulation into the Selectivity Mechanism Targeting Wang Z; Li G; Tian Z; Lou X; Huang Y; Wang L; Li J; Hou T; Liu JP J Phys Chem B; 2020 Nov; 124(44):9773-9784. PubMed ID: 33089692 [TBL] [Abstract][Full Text] [Related]
20. Rational design of small-molecules to recognize G-quadruplexes of c-MYC promoter and telomere and the evaluation of their in vivo antitumor activity against breast cancer. Long W; Zheng BX; Li Y; Huang XH; Lin DM; Chen CC; Hou JQ; Ou TM; Wong WL; Zhang K; Lu YJ Nucleic Acids Res; 2022 Feb; 50(4):1829-1848. PubMed ID: 35166828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]